NL192455C - - Google Patents

Download PDF

Info

Publication number
NL192455C
NL192455C NL8103101A NL8103101A NL192455C NL 192455 C NL192455 C NL 192455C NL 8103101 A NL8103101 A NL 8103101A NL 8103101 A NL8103101 A NL 8103101A NL 192455 C NL192455 C NL 192455C
Authority
NL
Netherlands
Prior art keywords
formula
ynyl
prop
dione
estr
Prior art date
Application number
NL8103101A
Other languages
English (en)
Dutch (nl)
Other versions
NL8103101A (nl
NL192455B (no
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Publication of NL8103101A publication Critical patent/NL8103101A/nl
Publication of NL192455B publication Critical patent/NL192455B/xx
Application granted granted Critical
Publication of NL192455C publication Critical patent/NL192455C/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/008—Ketals at position 17

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL8103101A 1980-06-27 1981-06-26 10-alkynylsteroiden. NL8103101A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16345180A 1980-06-27 1980-06-27
US16345180 1980-06-27

Publications (3)

Publication Number Publication Date
NL8103101A NL8103101A (nl) 1982-01-18
NL192455B NL192455B (no) 1997-04-01
NL192455C true NL192455C (no) 1997-08-04

Family

ID=22590066

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8103101A NL8103101A (nl) 1980-06-27 1981-06-26 10-alkynylsteroiden.

Country Status (23)

Country Link
US (1) US4322416A (no)
JP (1) JPS5738797A (no)
AT (1) AT385510B (no)
AU (1) AU542273B2 (no)
BE (1) BE889401A (no)
CA (1) CA1173431A (no)
CH (1) CH646984A5 (no)
DE (1) DE3124780A1 (no)
DK (2) DK161151C (no)
ES (1) ES503345A0 (no)
FR (1) FR2485543A1 (no)
GB (2) GB2078749B (no)
HK (1) HK72686A (no)
IE (1) IE51351B1 (no)
IL (1) IL63143A (no)
IT (1) IT1171339B (no)
MY (1) MY8700055A (no)
NL (1) NL8103101A (no)
NO (1) NO156693C (no)
NZ (1) NZ197494A (no)
PH (1) PH16787A (no)
SE (1) SE452325B (no)
ZA (1) ZA814220B (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3362176D1 (en) * 1982-07-14 1986-03-27 Akzo Nv Novel 19-thio-androstane derivatives
EP0114033B1 (de) * 1982-12-21 1988-10-12 Ciba-Geigy Ag Substituierte Azabicycloalkane, ihre Verwendung, pharmazeutische Präparate, welche diese Verbindungen enthalten, und Verfahren zur Herstellung dieser Verbindungen
DE3323321A1 (de) * 1983-06-24 1985-01-03 Schering AG, 1000 Berlin und 4709 Bergkamen Prophylaxe und therapie von koronaren herzkrankheiten durch senkung des oestrogenspiegels
DE3338212C2 (de) * 1983-10-18 1995-05-18 Schering Ag 1-Methyl-androsta-1,4,6-trien-3,17-dione, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
US4634694A (en) * 1984-01-14 1987-01-06 Akzo N.V. Novel Δ4 - and Δ5 -androstene derivatives and pharmaceutical compositions containing these derivatives
US4546098A (en) * 1984-04-13 1985-10-08 The Rockefeller University Estrogen synthesis inhibitors
FR2569408B1 (fr) * 1984-08-24 1986-10-03 Roussel Uclaf Nouveaux steroides substitues en position 10 par un radical comportant une double ou triple liaison, leur procede de preparation, leur application comme medicaments, les compositions pharmaceutiques les renfermant
GB8531747D0 (en) * 1985-12-24 1986-02-05 Erba Farmitalia 10beta-alkynylestrene derivatives
FR2594830B1 (fr) * 1986-02-24 1988-06-03 Roussel Uclaf Nouveaux 13 epi ou d-homo steroides substitues en position 10b par un radical comportant une double ou triple liaison, leur procede de preparation, leur application comme medicaments, les compositions pharmaceutiques les renfermant
FR2594829B1 (fr) * 1986-02-24 1988-06-03 Roussel Uclaf Nouveaux steroides 9 (11) satures substitues en position 10 par un radical comportant une triple liaison, leur procede de preparation, leur application comme medicaments, les compositions pharmaceutiques les renfermant
US4874891A (en) * 1986-05-01 1989-10-17 Washington University Open "D" ring hormone analogs
US4910191A (en) * 1988-06-28 1990-03-20 Merrell Dow Pharmaceuticals Inc. 19-substituted progesterone derivatives useful as 19-hydroxylase inhibitors
US4882322A (en) * 1988-10-27 1989-11-21 Merrell Dow Pharmaceuticals Inc. 3β,17β-hydroxy-substituted steroids and related steroidal compounds
FR2640976B1 (no) * 1988-12-22 1994-10-28 Roussel Uclaf
US5162337A (en) * 1990-10-05 1992-11-10 Merck & Co., Inc. Animal growth promotion
US5166201A (en) * 1990-11-30 1992-11-24 Merrell Dow Pharmaceuticals Inc. 2β,19-ethylene bridged steroids as aromatase inhibitors
US5126488A (en) * 1990-11-30 1992-06-30 Merrell Dow Pharmaceuticals Inc. 2β,19-methyleneamino bridged steroids as aromatase inhibitors
CH683151A5 (de) * 1991-04-24 1994-01-31 Ciba Geigy Ag Antikonzeption bei weiblichen Primaten ohne Beeinflussung des menstruellen Zyklus.
FR2677027B1 (fr) * 1991-05-27 1993-09-10 Roussel Uclaf Nouveaux produits sterouides substitues en position 6, et comportant, en position 10, un radical thioethyle, leur procede de preparation leurs intermediaires, leur application comme medicaments.
DE4435368A1 (de) * 1994-09-22 1996-03-28 Schering Ag Verwendung von Aromatasehemmern zur Herstellung eines Arzneimittels zur Behandlung eines relativen Androgenmangels beim Mann
US5866558A (en) * 1997-05-08 1999-02-02 Regents Of The University Of Minnesota 6-alkynyl steroids
EP1854465A1 (en) * 2006-05-12 2007-11-14 Alexander Tobias Teichmann Use of 4,17 beta-dihydroxyandrost-4-ene-3-one for treating cancers
AU2011237592B2 (en) 2010-04-08 2016-10-27 Emory University Substituted androst-4-ene diones
EP3666276A1 (en) 2018-12-14 2020-06-17 dcic Biopharmaceutical Limited Medication against estrogen-receptor beta (erbeta) positive breast tumor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3127427A (en) * 1962-07-17 1964-03-31 Hoffmann La Roche 10-alkenyl-steroids and process therefor
US3218316A (en) * 1963-08-26 1965-11-16 Syntex Corp 10beta-ethynyl-19-norandrostane derivatives

Also Published As

Publication number Publication date
NO812197L (no) 1981-12-28
NL8103101A (nl) 1982-01-18
IL63143A0 (en) 1981-09-13
NL192455B (no) 1997-04-01
DE3124780C2 (no) 1992-04-23
DK161151C (da) 1991-11-18
ES8302025A1 (es) 1983-01-01
IT1171339B (it) 1987-06-10
DK274681A (da) 1981-12-28
CH646984A5 (de) 1984-12-28
ATA285781A (de) 1987-09-15
NO156693B (no) 1987-07-27
AT385510B (de) 1988-04-11
AU542273B2 (en) 1985-02-14
GB2135314A (en) 1984-08-30
GB2135314B (en) 1985-04-17
ZA814220B (en) 1982-07-28
JPH021159B2 (no) 1990-01-10
JPS5738797A (en) 1982-03-03
AU7237081A (en) 1982-01-07
IL63143A (en) 1984-10-31
BE889401A (fr) 1981-12-28
IE51351B1 (en) 1986-12-10
IE811434L (en) 1981-12-27
DK75190A (da) 1990-03-22
GB2078749A (en) 1982-01-13
CA1173431A (en) 1984-08-28
DE3124780A1 (de) 1982-06-03
MY8700055A (en) 1987-12-31
DK75190D0 (da) 1990-03-22
ES503345A0 (es) 1983-01-01
FR2485543B1 (no) 1983-12-23
GB2078749B (en) 1983-11-16
SE452325B (sv) 1987-11-23
NZ197494A (en) 1984-11-09
IT8148780A0 (it) 1981-06-26
DK161151B (da) 1991-06-03
GB8316702D0 (en) 1983-07-20
US4322416A (en) 1982-03-30
SE8103963L (sv) 1981-12-28
FR2485543A1 (fr) 1981-12-31
PH16787A (en) 1984-02-22
DK162447B (da) 1991-10-28
DK162447C (da) 1992-03-23
NO156693C (no) 1987-11-04
HK72686A (en) 1986-10-03

Similar Documents

Publication Publication Date Title
NL192455C (no)
EP0190759B1 (de) 11 Beta-Phenyl-Gonane, deren Herstellung und diese enthaltende pharmazeutische Präparate
CA1173432A (en) 10-(1,2-propadienyl) steroids as irreversible aromatase inhibitors
WO1992004309A1 (en) Novel 15,16-seco-19-nor progestins
JPS61172896A (ja) 一定ステロイド類、殊にプロリゲストンおよび関連化合物製造中間体の新規製法、並びに該方法により形成された新規中間体
AU7511700A (en) Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11
KR100190776B1 (ko) 아로마타제억제제로서의2베타,19-에틸렌브릿지된스테로이드,이의제조방법및이를함유하는약제학적조성물
US4925834A (en) 3-methylene-4-androsten-17-ones, process for their production and pharmaceutical preparations containing them
US3483233A (en) 3 - cyanomethylene-androstenes and -oestrenes and process for their preparation
CA1069117A (en) PROCESS FOR THE PREPARATION OF 11.beta.-HYDROXY-18-ALKYL-ESTRANE COMPOUNDS
US4987128A (en) Novel 10β-alkynyl-steroids
US5457097A (en) Androst-4-eno[4,5-b]pyrrole derivatives
EP0047016B1 (en) Progesterone derivatives, process for their production, and pharmaceutical compositions
US3560533A (en) 17alpha - (2 - alkynyl) - 1 - methylestra - 1,3,5(10)-triene-3,17beta-diols and esters thereof
GB2191777A (en) Methylene derivatives of androst-4-ene-3,17-diones and process for their preparation
DE1493114C3 (no)
DE3213328A1 (de) 3,4,17-trioxygenierte 4,9(11)-androstadiene
NO118316B (no)
IE73240B1 (en) Steroids and therapeutic compositions containing same
SI8611201A8 (sl) Postopek za pridobivanje substituiranih androsta -1,4-dien-3,17-dionov

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
DNT Communications of changes of names of applicants whose applications have been laid open to public inspection

Free format text: MERRELL PHARMACEUTICALS INC.

V1 Lapsed because of non-payment of the annual fee

Effective date: 20010101